Gilead Sciences
GILD
GILD
1,594 hedge funds and large institutions have $61.3B invested in Gilead Sciences in 2022 Q2 according to their latest regulatory filings, with 141 funds opening new positions, 683 increasing their positions, 578 reducing their positions, and 119 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,594
Holders Change
+1
Holders Change %
+0.06%
% of All Funds
26.95%
Holding in Top 10
32
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+33.33%
% of All Funds
0.54%
New
141
Increased
683
Reduced
578
Closed
119
Calls
$1.14B
Puts
$780M
Net Calls
+$360M
Net Calls Change
+$209M
Top Buyers
| 1 |
BlackRock
New York
|
+$323M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$296M |
| 3 |
Morgan Stanley
New York
|
+$267M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$208M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$208M |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$209M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$209M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$159M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$149M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$148M |
